middle.news
PolyNovo’s wound platform gains momentum before key US filing
8:58am on Tuesday 15th of September, 2026 AEST
•
Medical Technology
Read Story
PolyNovo’s wound platform gains momentum before key US filing
8:58am on Tuesday 15th of September, 2026 AEST
Key Points
FY26 revenue rose 16.1% to A$149.984 million
Commercial product sales increased 16.7% to A$138.440 million
Operating cash flow climbed to A$23.109 million
U.S. PMA submission planned before the end of calendar 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Polynovo (ASX:PNV)
OPEN ARTICLE